CN Stock MarketDetailed Quotes

300111 Zhejiang Sunflower Great Health

Watchlist
  • 2.36
  • 0.000.00%
Market Closed Jul 12 15:00 CST
3.04BMarket Cap87.41P/E (TTM)

About Zhejiang Sunflower Great Health Company

The company was founded in 2005 and listed on the Shenzhen GEM in August 2010. The company is committed to investing in pharmaceuticals, health and high-tech industries. In the future, it will build a big health industry cluster for pharmaceutical innovation, medical devices and pharmaceutical services, and a high-tech industrial cluster in the direction of TMT to seize the opportunities of China's economic transformation. The company's vision is “Health carries dreams, and action achieves the future”. The company's main business focuses on the pharmaceutical field, mainly R&D, production and sales of anti-infective, cardiovascular, and digestive drugs. The leading products cover the fields of anti-infective drugs, cardiovascular drugs, digestive system drugs, etc.

Company Profile

Short Name-A向日葵
Symbol-A300111
Company NameZhejiang Sunflower Great Health Co., Ltd.
Listing DateAug 27, 2010
Issue Price16.80
Shares Offered51.00M share(s)
FoundedMar 21, 2005
Legal Representativeyang cao
General Managerhuaxin shi
Secretarylan li
Accounting FirmLixin Certified Public Accountants (special general partnership)
Legal CounselShanghai AllBright Law Firm
Employees25
Phone0575-88919159
Office AddressSanjiang Road, Paojiang Industrial Zone, Shaoxing City, Zhejiang Province
Zip Code312071
Registered AddressSanjiang Road, Paojiang Industrial Zone, Shaoxing, Zhejiang
Fax0575-88919159
Emailmichelle.li@sunowe.com
Business License330600400004037
BusinessGeneral projects: technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; manufacturing of basic chemical raw materials (excluding manufacture of licensed chemicals such as hazardous chemicals); investment activities with own funds; production of first-class medical devices; sales of first-class medical devices; sales of first-class medical devices; production of chemical products (excluding licensed chemical products); chemical product sales (excluding licensed chemical products); biochemical product technology research and development (except for projects subject to approval by law, independent business activities carried out in accordance with the law on the basis of a business license). Licensed items: pharmaceutical production; import and export of pharmaceuticals; import and export of technology; import and export of goods; production of Class II medical devices; production of Class III medical devices (projects subject to approval according to law, business activities can only be carried out after approval by relevant departments; specific business projects are subject to the approval results).

Company Executives

  • Name
  • Position
  • Salary
  • yang cao
  • Chairman,directors
  • 717.30K
  • feng wu
  • directors
  • --
  • huaxin shi
  • directors,general manager
  • 717.30K
  • weibiao pan
  • directors,Deputy General Manager,Chief Financial Officer
  • 566.30K
  • guohua liu
  • Independent directors
  • 107.40K
  • dongzhe sun
  • Independent directors,Audit Committee Member,Member of the Remuneration and Assessment Committee,Member of the Strategy Committee,Nomination Committee Members
  • 29.70K
  • suqin chen
  • Independent directors
  • 107.40K
  • lan li
  • Board Secretary
  • 413.10K
  • qiong wu
  • Chairman of the Supervisory Board,auditors
  • --
  • ji zhu
  • auditors
  • 150.30K
  • weijiang ping
  • Deputy General Manager
  • 515.60K
  • qidong han
  • Internal Audit Manager
  • --
  • zhihan lin
  • Employee supervisors
  • 215.90K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg